LATEST ALERTS
US company 22nd Century reports its full-year results for 2021, with a company loss but increased net sales, and plans for expansion for its VLN cigarettes both domestically and internationally
Swedish Match has reported an 11% sales increase in 2021 driven by the smoke-free product segment, with strong growth in the US and Scandinavia
The US Food and Drug Administration (FDA) has confirmed that a plan to ban menthol in combustible smoking products by the end of spring 2022 “remains on track”
British American Tobacco (BAT) saw revenue from its new products category portfolio rise by 42.4% in 2021 to £2.05bn, driven in part by an increase in sales of its modern oral products
22nd Century Group is to announce its full year results on 1st March, after confirming the launch of its two low-nicotine cigarettes as modified risk tobacco products
Philip Morris International (PMI) posted positive numbers for 2021, helped by higher unit volumes in heated tobacco and outstanding initial results from its fourth-generation heated tobacco device Iqos Iluma
Acceptance by the US FDA of very-low-nicotine cigarettes as a modified risk product may be controversial, even bizarre, but it will be worth seeing how they perform in the market – and how that may affect future regulation of alternatives
Consumers will continue to increasingly spread usage out over different alternative nicotine products partiy driven by further, stricter vaping regulation across the globe throughout 2022, TobaccoIntelligence predicts
Tobacco giant Altria’s net revenues slightly declined in 2021, partially offset by growth in the company’s oral tobacco products segment
Philip Morris’s bid to resume importing and selling its Iqos heat-not-burn (HnB) device in the US has failed
TobaccoIntelligence showed excellent understanding of the industry and a capacity for accurate analysis with its 2021 predictions, most of which hit during the year
The heated tobacco sector has, compared with its cousin vapour, always suffered from a lack of scientific research and from the perception that most of what does exist is industry-funded
Alternative tobacco products, including heated tobacco and nicotine pouches, have taken worldwide sales from combustibles over the past three years, with the cigarette segment declining by 5%
2021 may have been a downer in many other areas but the year saw phenomenal growth across tobacco alternatives, including in the oral segment, heated tobacco and nicotine pouches
The US FDA’s marketing authorisation of two low-nicotine cigarettes as modified risk tobacco products – including a menthol cigarette – has not gone down well with public health associations or all harm reduction experts
The prospect of very-low-nicotine cigarettes becoming the next alternative product on the US market has come a significant step closer, with the FDA issuing modified risk orders for two products from 22nd Century Group
The US Senate Finance Committee has made “targeted improvements” to president Joe Biden’s $2tn social spending package – including removing the proposal of a federal tax on tobacco alternatives
The US House of Representatives has passed by 220 votes to 213 president Joe Biden’s $1.75tn social spending bill, including a new federal tax on nicotine pouches
Robert Califf’s expected return to head the US FDA has excited plenty of attention in the world of e-cigarettes, but there’s been much less talk about the likely impact on heated tobacco, pouches and other novel nicotine products
Altria posted a 4.7% revenue decline in the third quarter of the year, mainly driven by the continuing poor performance of its smokable segment but neutralised by the growth of its oral products in the US
Swedish Match has reported 9% growth in global sales in the first nine months of 2021, driven by its smoke-free portfolio in the US and Scandinavia, but profit and market share have not lived up to forecast
The US Food and Drug Administration (FDA) has issued marketing authorisation for four mint-flavoured oral tobacco products that were withdrawn from the US market in 2019
While the decision to give marketing authorisation to some RJ Reynolds relates specifically to e-cigarette products, it’s highly likely that much the same priorities will govern official thinking on other alternative products
Philip Morris International (PMI)’s net revenues were up by 9.1% in the third quarter of 2021 thanks to the growth of its heated tobacco segment
Some light is now dawning on some truths long since suspected about the US Food and Drug Administration (FDA)’s approach to tobacco-alternative products of all kinds through its cumbersome evaluation of e-cigarettes
PMI and its distributor Altria Group must stop importing Iqos consumables in the US, according to a ruling issued by the US International Trade Commission (ITC)
Swedish Match has announced that the company is to become 100% smoke-free by next year with the separation of its cigar business in the US, a decision that is likely to have an impact in the market
As the US Food and Drug Administration’s deadline to pass or reject e-cigarette premarket tobacco product applications (PMTAs) arrives, where does it leave the market and what might it mean for tobacco alternatives?
Sales of nicotine pouches in the US have risen 300 times higher over the five years since they entered the US market in 2016, according to figures released by the US Centers for Disease Control and Prevention (CDC)
Both the House and Senate are intent on increasing the US Food and Drug Administration (FDA) budget for next year, but the figure is likely to be far short of the $6.5bn initially requested by president Joe Biden
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.
